ASK Biosimilars

Objectives

Developed by PCM Scientific, our CME division, the ASK Biosimilars programme aims to educate hospital pharmacists and oncologists in the United Kingdom, Germany, Spain, France, Italy, Japan, and Canada in their knowledge and clinical use of oncology biosimilars and the treatment of solid tumours.

Our approach

The programme began with three live webinars hosted by an international expert faculty. All live sessions were recorded and available on-demand via the ASK Biosimilars website. Additional educational resources such as a digital educational handbook, multiple learning chapters, an abstract resource library, and NRA summary guidelines were also produced and hosted via the ASK platform. To meet the knowledge gaps internationally, all the digital resources were translated into French, German, Italian, Spanish, and Japanese.

Using our brands Hospital Healthcare Europe and Hospital Pharmacy Europe, the resources were promoted to our community of hospital pharmacists and oncologists in the United Kingdom, Germany, Spain, France, Italy, Japan, and Canada. Promotion was also done via oncology pharmacy associations such as the British Oncology Pharmacy Association (BOPA) and Canadian Association of Pharmacy in Oncology (CAPhO).

This independent educational activity is supported by funding from Pfizer Inc. PCM Scientific is the medical education company acting as scientific secretariat and organiser for this programme. The activity is run independently of the financial supporter and all content is created by the faculty. No funder has had input into the content of the activity.

Outcome

• 16,280+ Unique engagements
• 185+ downloads of the digital educational handbook
• 100% of learners would engage in more ASK education
• 100% of learners found content relevant/partially relevant to their practice

The programme was a great success with impressive faculty feedback, and as a result we are now working towards expanding the programme.

“I just want to reiterate how wonderful it was to work with you and your team at PCM [Scientific]. Really hope we can work together on other projects in the future” – Glenn Myers, Clinical Pharmacist, Dr. Sheldon H Rubin Oncology Clinic, Moncton, New Brunswick, Canada.